Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Regulatory News (ZTF)

Share Price Information for Zotefoams (ZTF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 562.00
Bid: 564.00
Ask: 576.00
Change: -2.00 (-0.35%)
Spread: 12.00 (2.128%)
Open: 564.00
High: 574.00
Low: 562.00
Prev. Close: 564.00
ZTF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

10 Jun 2021 16:41

RNS Number : 5475B
Zotefoams PLC
10 June 2021
 

Zotefoams plc

(the 'Company')

 

NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PDMRs

10 June 2021 - On 8 June 2021, the Company received notice from its Employee Benefit Trust of the exercise of nil cost options granted over ordinary shares of 5 pence each ('Shares') under the Company's Long-Term Incentive Plan ('LTIP') and Deferred Bonus Share Plan ('DBSP') at a sale price of £4.77 as follows:

DIRECTORS

 

Award

Number of shares exercised

Number of shares retained

Number of shares sold for tax

Aggregate number of shares held

D B Stirling

 

DBSP 2020

36,018

Nil

Nil

449,162

DBSP 2017

6,893

Nil

Nil

LTIP 2017

37,978

Nil

Nil

LTIP 2018

5,425

Nil

Nil

G C McGrath

DBSP 2017

4,576

2,420

2,156

60,644

LTIP 2017

24,921

13,183

11,738

LTIP 2018

3,656

1,934

1,722

 

PDMRs

 

Award

Number of shares exercised

Number of shares retained

Number of shares sold for tax

K D Hewson

DBSP 2017

3,598

1,903

1,695

LTIP 2017

27,788

14,701

13,087

LTIP 2018

5,361

2,835

2,526

H D Morgan

DBSP 2017

1,975

1,044

931

LTIP 2017

16,321

8,634

7,687

LTIP 2018

4,932

2,609

2,323

D B Catalano

LTIP 2017

27,335

Nil

Nil

LTIP 2018

8,287

Nil

Nil

 

Awards granted under the LTIP vest subject to the satisfaction of performance targets over the three-year performance period. The final decision on the timing of vesting of the LTIP 2017 award was deferred for a period of up to one year. Following due consideration by the Committee, including taking into account the stability of the Group following the impact of COVID-19, the Remuneration Committee agreed that it would be appropriate to release the award in line with the formulaic outcome on 1 June 2021.

Awards granted under the DBSP usually vest three years from grant, subject to satisfaction of service conditions. However, given the unprecedented circumstances brought about by COVID-19, and the decision of the Board not to recommend a final dividend for the year ended 31 December 2019, the proportion of the bonus that would normally have been paid in cash under the DBSP 2020 Award was deferred into shares (the 'Deferred Bonus proportion'). The Remuneration Committee has now approved the exercise of the Deferred Bonus proportion taking place prior to 20 April 2023. The proportion of the bonus that would normally be deferred into shares (25%) will continue as normal and will be released after three years.

All awards were increased to reflect the dividends paid during the restricted period.

The Notification of Dealing Form can be found below.

 

This announcement is made in accordance with the requirements of Article 19 of the UK Market Abuse Regulation 596/2014.

 

Lydia Harratt

Group Company Secretary

Zotefoams plc

020 8664 1600

 

 

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology delivering optimal material solutions for the benefit of society. Utilising a variety of unique manufacturing processes, including environmentally friendly nitrogen expansion for lightweight AZOTE® polyolefin and ZOTEK® high-performance foams, Zotefoams sells to diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT® advanced insulation for demanding industrial markets. Zotefoams also owns and licenses patented microcellular foam technology to reduce plastic use in extrusion applications and for ReZorce® mono-material recyclable barrier packaging.

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky, USA and Brzeg, Poland (foam manufacture), Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA (MuCell Extrusion) and Jiangsu Province, China (T-FIT).

www.zotefoams.com

AZOTE®, ZOTEK®, ReZorce® and T-FIT® are registered trademarks of Zotefoams plc.

 

 

ZOTEFOAMS PLC

DEALING NOTIFICATION FORMFOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: David Burns Stirling

2.

Reason for the notification

a)

Position/status: Group CEO

b)

Initial notification/Amendment: Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Zotefoams plc

b)

LEI: 213800B6P256B5XN8D32

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 5 pence each

Identification code: GB0009896605

b)

Nature of the transaction: Exercise and sale of shares under the Long-Term Incentive Plan and the Deferred Bonus Share Plan

c)

Price(s) and volume(s):

Volume

Price

86,314

£4.77

 

d)

Aggregated information:

 

Aggregate Price

Aggregate Volume

Aggregate Total

£4.77

86,314

£411,717.78

 

e)

Date of the transaction: 8 June 2021

f)

Place of the transaction: XLON

 

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Gary Christopher McGrath

2.

Reason for the notification

a)

Position/status: Group CFO

b)

Initial notification/Amendment: Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Zotefoams plc

b)

LEI: 213800B6P256B5XN8D32

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 5 pence each

Identification code: GB0009896605

b)

Nature of the transaction: Exercise and sale of shares for tax under the Long-Term Incentive Plan and the Deferred Bonus Share Plan

c)

Price(s) and volume(s):

Volume

Price

15,616

£4.77

 

d)

Aggregated information:

 

Aggregate Price

Aggregate Volume

Aggregate Total

£4.77

15,616

£74,488.32

 

e)

Date of the transaction: 8 June 2021

f)

Place of the transaction: XLON

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 5 pence each

Identification code: GB0009896605

b)

Nature of the transaction: Exercise and retention of shares under the Long-Term Incentive Plan and the Deferred Bonus Share Plan

c)

Price(s) and volume(s):

Volume

Price

17,537

£4.77

 

d)

Aggregated information:

 

Aggregate Price

Aggregate Volume

Aggregate Total

£4.77

17,537

£83,651.49

 

e)

Date of the transaction: 8 June 2021

f)

Place of the transaction: XLON

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Karl David Hewson

2.

Reason for the notification

a)

Position/status: Senior Executive

b)

Initial notification/Amendment: Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Zotefoams plc

b)

LEI: 213800B6P256B5XN8D32

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 5 pence each

Identification code: GB0009896605

b)

Nature of the transaction: Exercise and sale of shares for tax under the Long-Term Incentive Plan and the Deferred Bonus Share Plan

c)

Price(s) and volume(s):

Volume

Price

17,308

£4.77

 

d)

Aggregated information:

 

Aggregate Price

Aggregate Volume

Aggregate Total

£4.77

17,308

£82,559.16

 

e)

Date of the transaction: 8 June 2021

f)

Place of the transaction: XLON

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 5 pence each

Identification code: GB0009896605

b)

Nature of the transaction: Exercise and retention of shares under the Long-Term Incentive Plan and the Deferred Bonus Share Plan

c)

Price(s) and volume(s):

Volume

Price

19,439

£4.77

 

d)

Aggregated information:

 

Aggregate Price

Aggregate Volume

Aggregate Total

£4.77

19,439

£92,724.03

 

e)

Date of the transaction: 8 June 2021

f)

Place of the transaction: XLON

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Hugh De Riemer Morgan

2.

Reason for the notification

a)

Position/status: Senior Executive

b)

Initial notification/Amendment: Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Zotefoams plc

b)

LEI: 213800B6P256B5XN8D32

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 5 pence each

Identification code: GB0009896605

b)

Nature of the transaction: Exercise and sale of shares for tax under the Long-Term Incentive Plan and the Deferred Bonus Share Plan

c)

Price(s) and volume(s):

Volume

Price

10,941

£4.77

 

d)

Aggregated information:

 

Aggregate Price

Aggregate Volume

Aggregate Total

£4.77

10,941

£52,188.57

 

e)

Date of the transaction: 8 June 2021

f)

Place of the transaction: XLON

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 5 pence each

Identification code: GB0009896605

b)

Nature of the transaction: Exercise and retention of shares under the Long-Term Incentive Plan and the Deferred Bonus Share Plan

c)

Price(s) and volume(s):

Volume

Price

12,287

£4.77

 

d)

Aggregated information:

 

Aggregate Price

Aggregate Volume

Aggregate Total

£4.77

12,287

£58,608.99

 

e)

Date of the transaction: 8 June 2021

f)

Place of the transaction: XLON

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Daniel Bryan Catalano

2.

Reason for the notification

a)

Position/status: Senior Executive

b)

Initial notification/Amendment: Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Zotefoams plc

b)

LEI: 213800B6P256B5XN8D32

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 5 pence each

Identification code: GB0009896605

b)

Nature of the transaction: Exercise and sale of shares under the Long-Term Incentive Plan and the Deferred Bonus Share Plan

c)

Price(s) and volume(s):

Volume

Price

35,622

£4.77

 

d)

Aggregated information:

 

Aggregate Price

Aggregate Volume

Aggregate Total

£4.77

35,622

£169,916.94

 

e)

Date of the transaction: 8 June 2021

f)

Place of the transaction: XLON

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEASKEFDNFEFA
Date   Source Headline
13th May 20143:31 pmRNSDirectorate Change
22nd Apr 201412:41 pmRNSUnilever to use MuCell technology for Dove bottles
14th Apr 20144:04 pmRNS2013 Annual Report & Accounts and Notice of AGM
9th Apr 20149:06 amRNSDirector/PDMR Shareholding
8th Apr 20148:16 amRNSDirector/PDMR Shareholding
18th Mar 20147:00 amRNSFinal Results
15th Jan 20147:00 amRNSTrading Update
19th Nov 20134:19 pmRNSHolding(s) in Company
23rd Oct 20137:00 amRNSTrading Update and Interim Management Statement
17th Oct 20131:21 pmRNSHolding(s) in Company
1st Oct 20132:13 pmRNSDirector Declaration
21st Aug 201312:15 pmRNSDirector/PDMR Shareholding
15th Aug 201312:26 pmRNSDirector/PDMR Shareholding
6th Aug 20137:00 amRNSHalf Yearly Report
12th Jul 20139:29 amRNSJoint Venture in Asia
8th Jul 20137:00 amRNSTrading Update
3rd Jun 201311:37 amRNSDirector/PDMR Shareholding
21st May 20139:43 amRNSDirector/PDMR Shareholding
15th May 201312:02 pmRNSResult of AGM
15th May 20137:00 amRNSAGM Statement and Interim Management Statement
29th Apr 20134:27 pmRNSDirector/PDMR Shareholding
10th Apr 20135:45 pmRNS2012 Annual Report and Accounts and AGM Notice
10th Apr 20132:22 pmRNSHolding(s) in Company (Replacement)
26th Mar 20131:01 pmRNSHolding(s) in Company
19th Mar 20135:43 pmRNSDirector/PDMR Shareholding
19th Mar 20135:40 pmRNSDirector/PDMR Shareholding
15th Mar 201310:00 amRNSHolding(s) in Company
12th Mar 20139:19 amRNSDirector/PDMR Shareholding
5th Mar 20137:00 amRNSFinal Results
18th Feb 20133:14 pmRNSChange of Advisers
9th Jan 20137:00 amRNSTrading Update
14th Nov 20129:56 amRNSDirector Declaration
26th Oct 20127:00 amRNSInterim Management Statement
14th Aug 201211:58 amRNSNotification of Major Interest in shares
14th Aug 20127:00 amRNSMuCell Extrusion LLC Obtains an Exclusive License
7th Aug 20127:02 amRNSHalf Yearly Report
7th Aug 20127:00 amRNSDow and MuCell Extrusion LLC Enter Agreement
9th Jul 20127:00 amRNSTrading Update
12th Jun 201212:15 pmRNSDirector/PDMR Shareholding
10th May 201212:08 pmRNSResult of AGM
10th May 20127:00 amRNSAGM and Interim Management Statement
13th Apr 201212:31 pmRNSHolding(s) in Company
13th Apr 201210:43 amRNSDirector/PDMR Shareholding
5th Apr 20123:25 pmRNSAnnual Information Update
5th Apr 201212:23 pmRNS2011 Annual Report & Accounts and Notice of AGM
5th Apr 201210:31 amRNSDirector/PDMR Shareholding
28th Mar 20128:43 amRNSHolding(s) in Company
6th Mar 20127:00 amRNSFinal Results
27th Jan 201210:57 amRNSHolding(s) in Company
19th Jan 20124:48 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.